Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Pulse Biosciences (PLSE) Return on Capital Employed (2021 - 2025)

Pulse Biosciences has reported Return on Capital Employed over the past 5 years, most recently at 0.75% for Q3 2025.

  • Quarterly results put Return on Capital Employed at 0.75% for Q3 2025, up 6.0% from a year ago — trailing twelve months through Sep 2025 was 0.75% (up 6.0% YoY), and the annual figure for FY2024 was 0.66%, up 5.0%.
  • Return on Capital Employed for Q3 2025 was 0.75% at Pulse Biosciences, down from 0.61% in the prior quarter.
  • Over the last five years, Return on Capital Employed for PLSE hit a ceiling of 0.51% in Q1 2025 and a floor of 1.88% in Q2 2022.
  • Median Return on Capital Employed over the past 5 years was 0.79% (2023), compared with a mean of 0.91%.
  • Biggest five-year swings in Return on Capital Employed: tumbled -102bps in 2022 and later surged 118bps in 2023.
  • Pulse Biosciences' Return on Capital Employed stood at 1.12% in 2021, then skyrocketed by 32bps to 0.76% in 2022, then decreased by -3bps to 0.78% in 2023, then grew by 30bps to 0.55% in 2024, then tumbled by -38bps to 0.75% in 2025.
  • The last three reported values for Return on Capital Employed were 0.75% (Q3 2025), 0.61% (Q2 2025), and 0.51% (Q1 2025) per Business Quant data.